1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of  incidence and mortality worldwide for 36 cancers in 185 countries. CA CancerJ Clin. 2024; 74(3): 229-263. doi: 10.3322/caac.21834.

2. Cancer in Ukraine 2016–2017. Incidence, mortality, activities of oncological service. ZP Fedorenko, YY Michailovich,LO Goulak, YL Gorokh, AY Ryzhov, … Bulletin of National cancerregistry of Ukraine. Vol. 19. Kyiv. 2018:136. http://www.ncru.inf.ua/publications/BULL_19/PDF_E/0-titul.pdf.

3. Bluethmann S. M., Mariotto A. B., Rowland J. H. Anticipatingthe “Silver Tsunami”: Prevalence Trajectories and ComorbidityBurden among Older Cancer Survivors in the United States.Cancer Epidemiol Biomarkers Prev. 2016. Jul;25(7):1029-36. doi:10.1158/1055-9965.EPI-16-0133.

4. Felix AS, Brinton LA. Cancer Progress and Priorities: Uterine Cancer. Cancer Epidemiol Biomarkers Prev. 2018 Sep; 27(9):985–994. doi: 10.1158/1055-9965.EPI-18-0264.

5. Bray, F., Ferlay, J., Soerjomataram, I., Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2018 Nov;68, 394-424. doi: 10.3322/caac.21492. Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313.doi: 10.3322/caac.21609.

6. Byeon J. S., Jeong J. Y., Kim M. J., Lee S. M., Nam W. H.,Myung S. J. et al. Adiponectin and adiponectin receptor in relation to colorectal cancer progression. Int. J. Cancer. 2010 Dec15;127:2758-67. doi: 10.1002/ijc.25301.

7. Stevens VL, Jacobs EJ, Sun J, McCullough ML, Patel AV,Gaudet MM, et al. Weight cycling and risk of endometrial cancer.Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):747-52. doi:10.1158/1055-9965.EPI-12-0038.

8. McCullough ML, Patel AV, Patel R, Rodriguez C, Feigelson HS, Bandera EV, et al. Body mass and endometrial cancerrisk by  hormone replacement therapy and cancer subtype.Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):73-9. doi:10.1158/1055-9965.EPI-07-2567.

9. Chang SC, Lacey JV Jr, Brinton LA, Hartge P, Adams K,Mouw T, et al. Lifetime weight history and endometrial cancerrisk by  type of  menopausal hormone use in  the NIH-AARPdiet and health study. Cancer Epidemiol Biomarkers Prev. 2007Apr;16(4):723-30. doi: 10.1158/1055-9965.EPI-06-0675.

10. Trentham-Dietz A, Nichols HB, Hampton JM, Newcomb PA.Weight change and risk of endometrial cancer. Int J Epidemiol.2006 Feb;35(1):151-8. doi: 10.1093/ije/dyi226.

11. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M.Body-mass index and incidence of cancer: a systematic reviewand meta-analysis of  prospective observational studies.Lancet. 2008 Feb 16;371(9612):569-78. doi: 10.1016/S0140-6736(08)60269-X.

12. Zhang X, Rhoades J, Caan BJ, Cohn DE, Salani R, Noria S,et al. Intentional weight loss, weight cycling, and endometrial cancer risk: a systematic review and meta-analysis. IntJ Gynecol Cancer. 2019 Nov;29(9):1361-1371. doi: 10.1136/ijgc-2019-000728.

13. Cleary MP, Grossmann ME. Minireview: Obesity andbreast cancer: the estrogen connection. Endocrinology. 2009Jun;150(6):2537-42. doi: 10.1210/en.2009-0070.

14. Christou NV, Lieberman M, Sampalis F, Sampalis JS.Bariatric surgery reduces cancer risk in morbidly obese patients.Surg Obes Relat Dis. 2008 Nov-Dec;4(6):691-5. doi: 10.1016/j.soard.2008.08.025.

15. Fang X, Wei J, He X, Lian J, Han D, An P, et al. Quantitative association between body mass index and the  riskof cancer: a global meta-analysis of prospective cohort studies. Int J Cancer. 2018 Oct 1;143(7):1595-1603. doi: 10.1002/ijc.31553.

16. Andò S, Catalano S. The multifactorial role of leptinindriving the breast cancer microenvironment. Nat Rev Endocrinol. 2011 Nov 15;8(5):263-75. doi: 10.1038/nrendo.2011.184.

17. Li ZJ, Yang XL, Yao Y, Han WQ, Li BO. Circulating adiponectin levels and risk of endometrial cancer: Systematic reviewand meta-analysis. Exp Ther Med. 2016 Jun;11(6):2305-13. doi:10.3892/etm.2016.3251.

18. Kabat GC, Xue X, Kamensky V, Lane D, Bea JW, Chen C,et al. Risk of breast, endometrial, colorectal, and renal cancersin postmenopausal women in association with a body shapeindex and other anthropometric measures. Cancer Causes Control. 2015 Feb;26(2):219-229. doi: 10.1007/s10552-014-0501-4.

19. Folsom AR, Kushi LH, Anderson KE, Mink PJ, Olson JE,Hong CP, et al. Associations of general and abdominal obesitywith multiple health outcomes in older women. Arch Intern Med.2000; Jul 24;160(14):2117-28. doi: 10.1001/archinte.160.14.2117.

20. Sinha R. Role of  addiction and stress neurobiologyon food intake and obesity. Biol Psychol. 2018 Jan;131:5-13.doi: 10.1016/j.biopsycho.2017.05.001.

21. Oliver, G. & Wardle, J. Perceived effects of stress on foodchoice. Physiol. Behav. 1999 May;66(3):511-5. doi: 10.1016/s0031-9384(98)00322-9.

22. Yau, Y. H. C. & Potenza, M. N. Stress and eating behaviors.Minerva Endocrinol. 2013 Sep;38(3):255-67. PMID: 24126546.

23. Tomiyama AJ. Stress and Obesity. Annu Rev Psychol. 2019Jan 4;70:703-718. doi: 10.1146/annurev-psych-010418-102936.

24. Chao AM, Jastreboff AM, White MA, Grilo CM, Sinha R.Stress, cortisol, and other appetite-related hormones: Prospective prediction of 6-month changes in food cravings andweight. Obesity (Silver Spring). 2017 Apr;25(4):713-720. doi:10.1002/oby.21790.

25. Herhaus, Benedict & Ullmann, Enrico & Chrousos, George& Petrowski, Katja. (2020) High/low cortisol reactivity and foodintake in people with obesity and healthy weight. TranslationalPsychiatry 10(40):1-8. doi: 10.1038/s41398-020-0729-6.

26. Опря Є. В., Єрмуракі П. П., Чернова Т. М., Горячев П. І.,Бєлогрудова К.  К., Донець О.  Ю. Запобігання конфліктамта  їх  вирішення на  заняттях у  медичному університеті  //Одеський медичний журнал. 2023. Т.  4  (185). С.  99—102.Oprya Ye. V., Yermuraki P. P., Chernova T. M., Horiachev P. I.,Bielohrudova K.  K., Donets  O.  Iu. [Conflict prevention andresolution in classes at a medical university]. [Odessa MedicalJournal]. 2023;4(185):99-102. https://doi.org/10.32782/2226-2008-2023-4-19. (In Ukrainian).

27. Perego M, Tyurin VA, Tyurina YY, Yellets J, Nacarelli T,Lin C, et al. Reactivation of dormant tumor cells by modifiedlipids derived from stress-activated neutrophils. Sci TranslMed. 2020 Dec 2;12(572):eabb5817. doi: 10.1126/scitranslmed.abb5817.

28. Nakane, T., Szentendrei, T., Stern, L., Virmani, M., Seely, J.,& Kunos, G. (1990). Effects of IL-1 and cortisol on beta-adrenergicreceptors, cell proliferation, and differentiation in cultured human A549 lung tumor cells. J Immunol. 1990 Jul 1;145(1):260-6.PMID: 2162889.

29. Балицкий, К. П., & Шмалько, Ю. П. Стресс и метастазирование злокачественных опухолей. Киев, 1987. 248 с.Balytskyi, K. P., & Shmalko, Yu. P. [Stress and metastasis of malignant tumors]. Kyiv, 1987. 248 p. [In Russian].

30. Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, Li Y, Gershenson DM, Lutgendorf S, Cole SW. Stresshormone-mediated invasion of ovarian cancer cells. Clin Cancer Res. 2006 Jan 15;12(2):369-75. doi: 10.1158/1078-0432.CCR-05-1698.

31. Kang DH, Park NJ, McArdle T. Cancer-specific stressand mood disturbance: implications for symptom perception,quality of life, and immune response in women shortly afterdiagnosis of breast cancer. ISRN Nursing. 2012;2012:608039.doi: 10.5402/2012/608039.

32. Arem H, Pfeiffer RM, Moore SC, Irvin M. L., LaMonte MJ,Sarto GE, [et al.] Post-diagnosis body mass index and mortality among women diagnosed with endometrial cancer:Results from the Women’s  Health Initiative. PLoS One. 2017Feb 2;12(2):e0171250. doi: 10.1371/journal.pone.0171250.

33. Laoutidis Z. G., Mathiak K. Antidepressants in the treatment of depression/depressive symptoms in cancer patients:a systematic review and meta-analysis. BMC Psychiatry. 2013May 16;13:140. doi: 10.1186/1471-244X-13-140.

34. Riblet N., Larson R., Watts B. V., Holtzheimer P. Reevaluating the role of antidepressants in cancer-related depression:a systematic review and meta-analysis. Gen Hosp Psychiatry. 2014Sep-Oct;36(5):466-73. doi: 10.1016/j.genhosppsych.2014.05.010.

35. Scheja L, Heeren J. The endocrine function of adiposetissues in health and cardiometabolic disease. Nat Rev Endocrinol. 2019 Sep;15(9):507-524. doi: 10.1038/s41574-019-0230-6.

36. Бугайцов С. Г. Рак молочної залози — реабілітація,корекція психосоматичних розладів в процесі комплексноголікування [автореферат]. Київ  : Інститут онкології АМНУкраїни, 2003 / Buhaitsov S H. [Breast cancer – rehabilitation,correction of psychosomatic disorders in the process of complextreatment] URI: https://www.docsity.com/ru/docs/rak-molochnoji-zalozi-reabilitaciya-korekciya-psihosomatichnih-rozladivv-procesi-kompleksnogo-likuvannya/1482620/. (In Ukrainian).

37. Kerschbaum E, Nüssler V. Cancer Prevention with Nutrition and Lifestyle. Visc Med. 2019 Aug;35(4):204-209. doi:10.1159/000501776.

38. Contreras García E, Zaragoza-Marti A. Influencia de laingesta de alimentos o grupos de alimentos en la aparición y/oprotección de los diversos tipos de cáncer: revisión sistemática[Influence of food or food groups intake on the occurrenceand/or protection of different types of cancer: systematicreview]. Nutr Hosp 2020 Feb 17;37(1):169-192. doi: 10.20960/nh.02588 (In Spanish).

39. Meynet O, Ricci JE. Caloric restriction and cancer: molecular mechanisms and clinical implications. Trends Mol Med.2014 Aug;20(8):419-27. doi: 10.1016/j.molmed.2014.05.001.

40. McDonald PG, Antoni MH, Lutgendorf SK, Cole SW,Dhabhar FS, Sephton SE, et al. A biobehavioral perspectiveof  tumor biology. Discov Med. 2005 Dec;5(30):520-6. PMID:20704834.

41. Центр медичної статистики МОЗ України: УкраїнськаБаза Медико-статистичної Інформації «Здоров’я для всіх» /Center for Medical Statistics of the Ministry of Health of Ukraine:Ukrainian Database of Medical and Statistical Information”Health for All” URL: http://medstat.gov.ua/ukr/normdoc.html.(In Ukrainian).

42. Green, B. L., Rowland, J. H., & Krupnick, J. L., Epstein SA,Stockton P, Stern NM, et al. Prevalence of posttraumatic stressdisorder in women with breast cancer. Psychosomatics. 1998Mar-Apr;39(2):102-11. doi: 10.1016/S0033-3182(98)71356-8.

43. Chan MK, Bhatti H, Meader N, Stockton S, Evans J,O’Connor RC, et al. Predicting suicide following self-harm:A systematic review of risk factors and risk scales. Br J Psychiatry. 2016 Oct;209(4):277-283. doi: 10.1192/bjp.bp.115.170050.

44. Lutgendorf SK, DeGeest K, Dahmoush L, Farley D, Penedo F, Bender D, et al. Social isolation is associated with elevatedtumor norepinephrine in ovarian carcinoma patients. Brain BehavImmun. 2011 Feb;25(2):250-5. doi: 10.1016/j.bbi.2010.10.012.

45. Montgomery M, & McCrone SH. Psychological distressassociated with the diagnostic phase for suspected breastcancer: systematic review. J Adv Nurs. 2010 Nov;66(11):2372-90.doi: 10.1111/j.1365-2648.2010.05439.x.

46. Корсун С. І., Ткачук Т. А. Психологія діяльності працівників податкової міліції : монографія. Київ, 2013. 194 с. /Korsun S. I., Tkachuk T. A. [Psychology of the activity of tax police officers: monograph]. Kyiv, 2013. 194 p. https://www.myslenedrevo.com.ua/uk/Sci/Philosophy/PsychologyTax.html. (In Ukrainian).

47. Rodin G, Lo C, Rydall A, Malfitano C, Chiu A, Panday T, et al.Managing cancer and living meaningfully (CALM): A randomizedcontrolled trial of a psychological intervention for patients withadvanced cancer. J Clin Oncol. 2018 Aug 10;36(23):2422-2432.doi: 10.1200/JCO.2017.77.1097.

48. Grossert, A., Urech, C., Alder, J. et al. Web-based stressmanagement for newly diagnosed cancer patients (STREAM-1):a  randomized, wait-list controlled intervention study. BMCCancer. 2016;16:838. doi: 10.1186/s12885-016-2866-0.

49. Duijts SF, Faber MM, Oldenburg HS, van Beurden M,Aaronson NK. Effectiveness of behavioral techniques and physicalexercise on psychosocial functioning and health‐related qualityof life in breast cancer patients and survivors—a meta‐analysis.Psychooncology. 2011 Feb;20(2):115-26. doi: 10.1002/pon.1728.

50. Rossi, E. L. (2000). In search of a deep psychobiology of hypnosis: Visionary hypotheses for a new millennium.American Journal of Clinical Hypnosis, 42(3–4), 178–207. doi:10.1080/00029157.2000.10734360.

51. Antoni MH, Lutgendorf SK, Blomberg B, Carver CS, Lechner S, Diaz A, et al. Cognitive-behavioral stress managementreverses anxiety-related leukocyte transcriptional dynamics.Biol Psychiatry. 2012 Feb 15;71(4):366-72. doi: 10.1016/j.biopsych.2011.10.007.

52. Терещенко, А. Ведение дистресса у  пациентовс онкологическими заболеваниями  // Здоров’я України.Онкологія. 2016, Червень. 2(43), 42–43. / Tereshchenko, A.[Management of distress in patients with oncological diseases]. [Health of Ukraine. Oncology]. 2016 Jun;2(43):42–43.(In Ukrainian).

53. Хомич, Г.  О. Психологічна допомога онкохвориму процесі консультування // Проблеми сучасної психології.2011. Т. 13. С. 596—605. Khomych, G. O. [Psychological assistance to cancer patients in the counseling process]. [Problemsof modern psychology]. 2011;13:596–605. (In Ukrainian).

54. Матреницький, В. Л. Забута психоонкологія: про необхідність психотерапії та психосоціальної реабілітації у профілактиці рецидивів та метастазів онкозахворювань // Клінічнаонкологія. 2018. Т. 8, № 1 (29). С. 46—52. / Matrenytskyi, V. L.[Forgotten psycho-oncology: on the necessity of psychotherapyand psychosocial rehabilitation in the prevention of relapses andmetastases of cancer]. [Clinical Oncology]. 2018; 8, 1(29):46–52.https://www.clinicaloncology.com.ua/article/20963/zabytayapsixoonkologiya-o-neobxodimosti-psixoterapii-i-psixosocialnojreabilitacii-v-profilaktike-recidivov-i-metastazov-onkozabolevanij.(In Ukrainian).

55. Cruess DG, Antoni MH, McGregor BA, Kilbourn KM,Boyers AE, Alferi SM, et al. Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit findingamong women being treated for early stage breast cancer. Psychosom Med. 2000 May-Jun;62(3):304-8. doi: 10.1097/00006842-200005000-00002.

56. van der Pompe G, Antoni MH, Duivenvoorden HJ, de GraeffA, Simonis RF, van der Vegt SG, Heijnen CJ. An exploratory studyinto the effect of group psychotherapy on cardiovascular and immunoreactivity to acute stress in breast cancer patients. PsychotherPsychosom. 2001 Nov-Dec;70(6):307-18. doi: 10.1159/000056271.

57. Матреницький, В. Л. Про психосоматичну схильністьдо раку // Міжнародний журнал загальної та медичної психології. 2019. Т. 4, № 4. С. 20—33. / Matrenytskyi, V. L. (2019).On the psychosomatic predisposition to cancer. InternationalJournal of General and Medical Psychology. 2019;4(4):20–33.(In Ukrainian).

58. Laoutidis Z. G., Mathiak K. Antidepressants in the treatment of depression/depressive symptoms in cancer patients:a systematic review and meta-analysis. BMC Psychiatry. 2013May 16;13:140. doi: 10.1186/1471-244X-13-140.

59. Li M, Kennedy EB, Byrne N, Gérin-Lajoie C, Katz MR, Keshavarz H, et al. Systematic review and meta-analysis of collaborative care interventions for depression in patients with cancer.Psychooncology. 2017 May;26(5):573-587. doi: 10.1002/pon.4286.

60. Denlinger CS, Sanft T, Baker KS, Baxi S, Broderick G, DemarkWahnefried W, et al. Survivorship. Version 2.2017, NCCN ClinicalPractice Guidelines in Oncology. J Natl Compr Canc Netw. 2017Sep;15(9):1140-1163. doi: 10.6004/jnccn.2017.0146.

61. Holland, J. C.; Breitbart, W. S.; Butow, P. N.; Jacobsen, P. B.;Loscalzo, M. J.; McCorkle, R. Psycho-Oncology. 3rd ed. Oxford: University Press, 2015. 770 p. 10.1093/med/9780199363315.001.0001.

62. Sharpley CF, Bitsika V, Christie DR. Factor structureof  a  combined measure of  major depressive disorder andmale depression in prostate cancer patients. Psychooncology.2016Apr;25(4):475-7. doi: 10.1002/pon.3928.

63. Мухаровська І. Р. Аналіз особливостей організаціїмедико-психологічної допомоги для пацієнтів онкологічногопрофілю / Mukharovska I. R. [Analysis of the features of the organization of medical and psychological care for oncologicalpatients]. Science Rise: Medical science. 2016;9(5):25–30. DOI:10.15587/2519-4798.2016.77849. (In Ukrainian).